賓達(dá)氮芥
| 中文名稱(chēng) | 賓達(dá)氮芥 |
|---|---|
| 中文同義詞 | 賓達(dá)氮芥;苯達(dá)莫司汀;4-[5-[雙(2-氯乙基)氨基]-1-甲基苯并咪唑-2-基]丁酸;鹽酸苯達(dá)莫司汀/4-[5-[雙(2-氯乙基)氨基]-1-甲基苯并咪唑-2-基]丁酸;4-(5-(雙(2-氯乙基)氨基)-1-甲基-1H-苯并[D]咪唑-2-基)丁酸;賓達(dá)氮芥,10 MM DMSO 溶液 |
| 英文名稱(chēng) | Bendamustine |
| 英文同義詞 | 5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid;5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid;Bendamustine;-1-methyl-1H-benzo[d]imidazol-2-yl);4-(5-(Bis(2-chloroethyl);1H-BenziMidazole-2-butanoicacid, 5-[bis(2-chloroethyl)aMino]-1-Methyl-;4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid;BendamustineQ: What is Bendamustine Q: What is the CAS Number of Bendamustine Q: What is the storage condition of Bendamustine Q: What are the applications of Bendamustine |
| CAS號(hào) | 16506-27-7 |
| 分子式 | C16H21Cl2N3O2 |
| 分子量 | 358.26 |
| EINECS號(hào) | |
| 相關(guān)類(lèi)別 | 雜環(huán)類(lèi);化工 |
| Mol文件 | 16506-27-7.mol |
| 結(jié)構(gòu)式 |  |
賓達(dá)氮芥 性質(zhì)
| 沸點(diǎn) | 585.2±50.0 °C(Predicted) |
|---|---|
| 密度 | 1.31±0.1 g/cm3(Predicted) |
| 儲(chǔ)存條件 | -20°C, protect from light |
| 溶解度 | DMSO：100 mg/mL（279.13 mM；需要超聲波） |
| 形態(tài) | 固體 |
| 酸度系數(shù)(pKa) | 4.50±0.10(Predicted) |
| 顏色 | 白色至米白色 |
DNA Alkylator/Crosslinker
Bendamustine is a DNA cross-linking agent that causes DNA breaks, with alkylating and antimetabolite properties. Bendamustine uniquely regulates apoptosis pathways and DNA repair pathways in non-Hodgkin's lymphoma cells. Bendamustine (50 μM) induces p21 (Cip1/Waf1) and NOXA genes, and increases the expression of p53 in SU-DHL-1 cells. Bendamustine (25 μM) blocks mitotic checkpoints and cuases mitotic catastrophe.
Bendamustine reduces the viability of multiple myeloma (MM) cell lines, such as RPMI-8226 and 8226-LR5 cells, with IC
25
s of 101.8 μM and 585.5 μM after 24 h incubation, and 51.7 and 374.3 μM after 48 h incubation, respectively. Bendamustine induces a specific caspase-dependent MM cell death and inhibits the spindle-assembly checkpoint.
Bendamustine (25 mg/kg, i.v.) shows potent inhibition on the growth of tumor cells by 91%, 99% and 95% for DoHH-2, Granta 519 and RAMOS models, respectively. Moreover, the antitumor effect of Bendamustine is enhanced by rituximab in DoHH-2 and RAMOS models, but not in Granta 519 model.
安全信息
| 毒害物質(zhì)數(shù)據(jù) | 16506-27-7(Hazardous Substances Data) |
|---|
| 更新日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱(chēng) | CAS號(hào) | 包裝 | 價(jià)格 |
|---|---|---|---|---|---|
| 2025/02/05 | S5939 | 賓達(dá)氮芥 Bendamustine | 16506-27-7 | 5mg | 959.1元 |
| 2025/02/05 | S5939 | 賓達(dá)氮芥 Bendamustine (SDX105) | 16506-27-7 | 10mM (1mL in DMSO) | 1122.03元 |